Maria Eugénia Santos Silva

Dr. Maria Eugénia Santos Silva


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2006 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
Maria João BugalhoMaria João Bugalho
Maria João Bugalho
EMEvelina Mendonça
Evelina Mendonça
PCPatrícia Costa
Patrícia Costa
JSJorge Rosa Santos
Jorge Rosa Santos
MSMaria Eugénia Santos Silva
Maria Eugénia Santos Silva
LSLuís G Sobrinho
Luís G Sobrinho
Secondary involvement of the thyroid gland is rare. Often the origin of the tumor is difficult to identify from the material obtained by fine-needle aspiration cytology. Renal cell carcinoma of the clear-cell type is one of the more common carcinomas to metastasize to the thyroid gland. Somatic mutations of the von Hippel-Lindau tumor suppressor gene are associated with the sporadic form of this tumor. We aimed to illustrate the potential utility of DNA based technologies to search for specific molecular markers in order to establish the anatomic site of origin. A 54-yr-old Caucasian male complaining of a rapidly increasing neck tumor was diagnosed as having a clear-cell tumor by fine-needle aspiration cytology. A positive staining for cytokeratin as well as for vimentin and CD10 in the absence of staining for thyroglobulin, calcitonin and TTF1 suggested a renal origin confirmed by computed tomography. Using frozen RNA, obtained from cells left inside the needle used for fine needle aspiration cytology, it was possible to identify a somatic mutation (680 delA) in the VHL gene. In the presence of a clear-cell tumor of the thyroid gland, screening for somatic mutations in the VHL gene in material derived from thyroid aspirates might provide additional information to immunocytochemical studies and therefore plays a contributory role to establish the final diagnosis. Moreover, in a near future, this piece of information might be useful to define a targeted therapy.

27 February 2023 in EJVES Vascular Forum
Verified
Journal Article
Open access
MSMaria Eugénia Santos Silva
Maria Eugénia Santos Silva
CNCelso Nunes
Celso Nunes
LBLeonor Baldaia
Leonor Baldaia
MCMiguel Castro
Miguel Castro
VOVânia Constâncio Oliveira
Vânia Constâncio Oliveira
LALuís F. Antunes
Luís F. Antunes
Endoleaks are a common complication following endovascular aneurysm repair, yet type IIIb are rare, especially with newer devices, and associated with high morbidity due to repressurisation of the sac. As endografts are used in patients with longer life expectancy, late type IIIb endoleaks are to be expected. This is a report of a giant common iliac aneurysm resulting from a misdiagnosed type IIIb endoleak. An 85 year old man with history of right common iliac artery aneurysm, treated in 2003 with an EXCLUDER AAA Endoprosthesis (WL Gore, Flagstaff, AZ, USA) with iliac limb extension into the external iliac artery, presented at the emergency department with abdominal pain, hypotension, and syncope. He had a known endoleak, unsuccessfully treated by relining the right iliac stent graft overlap zones for a suspected type IIIa endoleak (2009), coil embolisation, and computed tomography (CT) guided thrombin injection of the aneurysmatic sac for a type II (2010), none of which managed to treat the cause with continuous aneurysm growth. The patient refused further treatments, but agreed to maintain surveillance. At admission, CT angiography showed common iliac aneurysm (185 × 134 mm) sac rupture without a visible endoleak. Resuscitative endovascular balloon occlusion of the aorta (REBOA) technique was performed to obtain haemodynamic control, then the aneurysm was approached through a midline incision. A type IIIb endoleak was identified due to a fabric tear on the right iliac limb extension. Suture was attempted without success, then relining of the lesion with an Endurant II Limb (Medtronic, Minneapolis, MN, USA) was performed, which managed to repair the endoleak. Type IIIb endoleaks are uncommon and underdiagnosed due to fabric defects being too small or leaking intermittently. They can mimic other types of endoleaks and may cause aneurysm growth and rupture. One should consider this type of endoleak if previous treatments for other types were unsuccessful.

9 July 2026 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
MRMariana Rosado-Fonseca
Mariana Rosado-Fonseca
MSMaria Eugénia Santos Silva
Maria Eugénia Santos Silva
TRTiago Ribeiro
Tiago Ribeiro
MSMaria Antónia da Rocha Melo de Sousa
Maria Antónia da Rocha Melo de Sousa
DSDaniela Santos Silva
Daniela Santos Silva
JRJoao Rocha-Neves
Joao Rocha-Neves
Background: Wound healing in chronic limb-threatening ischaemia in peripheral artery disease (PAD) remains clinically challenging. Accurate perfusion assessment may predict limb outcomes. Standard measures ankle-brachial index (ABI) and transcutaneous oxygen pressure have limitations. The ABI, the guideline-recommended first-line diagnostic tool, has well-recognised limitations in patients. Pedal acceleration time (PAT), measured by duplex ultrasound from onset to peak arterial systole in the pedal arteries, shows promise as a prognostic marker, though its diagnostic and prognostic performance has not been fully validated. This study aimed to perform a systematic review and meta-analysis evaluating PAT’s diagnostic accuracy compared with ABI in detecting lower-limb ischaemia. Secondary objectives included assessing PAT’s prognostic value for wound healing and amputation risk. Methods: Three electronic databases MEDLINE, Scopus, and Web of Science, were systematically searched for studies evaluating PAT values and wound healing in PAD patients. Wound healing incidence and PAT-ABI correlations were pooled according to Preferred Reporting Items for Systematic reviews and Meta-Analyses of Diagnostic Test Accuracy studies (PRISMA-DTA) guidelines. Pooled diagnostic indices, including sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio with 95% confidence intervals were calculated. Study quality was assessed using the National Heart, Lung, and Blood Institute (NHLBI) Study Quality Assessment Tool for observational cohort and cross-sectional designs. Results: Seventeen studies (1749 patients) were included as following: 8 cross-sectional, 1 observational prospective, 3 observational retrospective, 4 cohort (3 retrospective, 1 prospective), and 1 case-control study. PAT demonstrated good diagnostic accuracy with pooled 0.72 (95% CI 0.68–0.76) sensitivity, 0.84 (95% CI 0.79–0.88) specificity, 4.38 (95% CI 3.35–5.73) positive likelihood ratio, 0.25 (95% CI 0.19–0.33) negative likelihood ratio, and 14.85 (95% CI 10.02–22.01) diagnostic odds ratio, indicating robust discrimination compared to ABI. The selected studies, referring to the period 2019–2025, reported an association between higher PAT values and worse wound healing outcomes and increased amputation risk. Due to insufficient and non-standardised data, PAT’s prognostic pooled analysis for wound healing was not feasible. Conclusion: PAT accurately detected clinically significant lower-limb ischaemia compared to ABI. Faster PAT values correlated to higher ABI and favorable wound healing outcomes, whereas prolonged PAT indicated higher risk of non-healing wounds and major amputation. These results support PAT as a useful duplex-based complement to existing perfusion tests.

22 March 2022 in EJVES Vascular Forum
Verified
Journal Article
Open access
VOVânia Constâncio Oliveira
Vânia Constâncio Oliveira
PLPedro Lima
Pedro Lima
JSJoana Cruz Silva
Joana Cruz Silva
CNCelso Nunes
Celso Nunes
MSMaria Eugénia Santos Silva
Maria Eugénia Santos Silva
MFManuel Fonseca
Manuel Fonseca

10 March 2026 in Cancers
Verified
Journal Article
Open access
PDF file
MMMadalena Silveira Machado
Madalena Silveira Machado
MSMadalena P. Santos
Madalena P. Santos
CRCatarina Relvas
Catarina Relvas
MPMargarida Quinto Pereira
Margarida Quinto Pereira
MSMafalda Sousa
Mafalda Sousa
HNHUGO SEABRA MARTINS NUNES
HUGO SEABRA MARTINS NUNES
Background: Obesity is increasingly prevalent and has been associated with poorer outcomes and higher toxicity in breast cancer treatment. Its impact on tolerance to neoadjuvant chemotherapy (NAC) remains understudied. Objectives: This study aimed to determine the prevalence of overweight and obesity among patients with high-risk early-stage breast cancer (BC) treated with NAC. It evaluated the association between obesity and clinically significant chemotherapy-related toxicities. Pathological complete response (pCR), progression-free survival (PFS), and overall survival (OS) were explored. Methods: This is a retrospective cohort study on stage I–III BC assigned for NAC between January 2020 and December 2022. Patients were categorized by body mass index. Patients with obesity were compared with an age-matched non-obese cohort (1:1). The toxicities evaluated were hospitalization, dose reduction, treatment delay, or treatment discontinuation. Multivariable logistic regression models were performed, adjusting for age, comorbidity burden, and carboplatin use. Results: Of 487 eligible patients, 31.2% were overweight and 27.7% were obese. Peripheral neuropathy was more frequent and severe in obese patients (63.7% vs. 36.3%, p < 0.001). In multivariable analysis, obesity was independently associated with increased odds of global toxicity (OR = 1.83; 95% CI: 1.08–3.15; p = 0.027) and treatment discontinuation (OR = 2.30; 95% CI: 1.18–4.59; p = 0.016). Conclusions: Obesity is highly prevalent among high-risk early BC patients. It is independently associated with increased treatment-related toxicity, particularly discontinuation. These findings highlight the need for closer toxicity monitoring in patients with obesity. Reliance on BMI alone may be insufficient, underscoring the potential value of incorporating body composition assessment into clinical practice.

2 February 2024 in EJVES Vascular Forum
Verified
Journal Article
Open access
LBLeonor Baldaia
Leonor Baldaia
TOTiago dos Santos Oliveira
Tiago dos Santos Oliveira
MSMaria Eugénia Santos Silva
Maria Eugénia Santos Silva
JMJoana Moreira
Joana Moreira
LALuís F. Antunes
Luís F. Antunes
Introduction: Popliteal artery aneurysms (PAAs) pose some challenges in their surgical management and are often treated by exclusion and bypass procedures. However, post-operative complications, such as endoleaks and sac growth, can occur, potentially leading to serious consequences. Endoleaks, characterised by persistent flow within the aneurysm sac after repair, can cause sac expansion, increasing the risk of adverse outcomes, including the formation of cutaneous fistulae, a rare but potentially severe complication. Report: A 75 year old male with a history of previous bilateral PAA exclusion with a left femoropopliteal bypass using reversed great saphenous vein (GSV) graft in 2012 and a right femoropopliteal bypass using a PTFE prosthesis in 2017, both through medial approach, presented with pain and ulceration in the left popliteal region. Previous angiography had shown residual arterial flow through collateral vessels, requiring thrombin injection. Bilateral bypass thrombosis had also occurred after discontinuing anticoagulation. Computed tomography angiography confirmed a complicated excluded left popliteal aneurysm with superinfection. The patient underwent elective surgery, involving partial aneurysmectomy, endoaneurysmorrhaphy, and fistulectomy through a posterior approach. Post-operatively, the patient experienced resolution of symptoms and inflammatory signs. Discussion: The optimal approach for treating PAAs remains a subject of debate, with some experts advocating the posterior approach to prevent sac growth. However, others support the medial approach, reporting satisfactory results. In this case, the medial approach resulted in incomplete exclusion, leading to sac expansion and a cutaneous fistula. Timely re-intervention through the posterior approach successfully resolved the complication. This report highlights a rare but serious complication of incomplete PAA exclusion. Vigilant post-operative surveillance and intervention are crucial to manage such cases effectively. Further research is warranted to determine the optimal approach for PAA repair and prevent associated complications.